Mineralys Therapeutics, Inc. MLYS Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s common stock, shares, outstanding?
- Mineralys Therapeutics, Inc. (MLYS) reported common stock, shares, outstanding of $82.45M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s common stock, shares, outstanding changed year-over-year?
- Mineralys Therapeutics, Inc.'s common stock, shares, outstanding increased by 27.1% year-over-year, from $64.88M to $82.45M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s common stock, shares, outstanding?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s common stock, shares, outstanding has grown at a 133.3% compound annual growth rate (CAGR), from $6.42M to $81.54M.